Search Results for “research” – Page 267 – media

Five tips for exploring pharmaceutical drug export markets

For pharmaceutical companies who want to explore international markets, identifying these target markets is the first step. Being able to pinpoint the right target market, will increase the probability for more business deals. In order to help you with this process, we have listed 5 of the more important aspects to consider.
- Source: Ddu
- 808
- March 9, 2018
Ddu College pharmaceutical
Epigenetic Dysregulation May Be Key to Onset

Greater than 90% of all Alzheimer’s disease (AD) cases are sporadic, meaning there are few hereditary risk factors for developing the disease. Although certain genetic variants increase the risk of AD, age is the strongest known risk factor. Yet, understanding how the underlying molecular mechanisms of aging predispose individuals to AD has remained elusive. Now, a team of researchers from the Perelman School of Medicine at the University of Pennsylvania have discovered what they believe are changes to the normal epigenetic landscape that lead to the onset of Alzheimer’s.
- Source: Pixabay
- 587
- March 9, 2018
Alzheimer's Researches
Eisai and Purdue Pharma Announce Positive Topline Results From Key Clinical Studies of Lemborexant Including First-Ever Phase 3 Head-to-Head Superiority Comparison Versus Zolpidem ER in Patients With Sleep Disorder

Eisai Co., Ltd. (CEO: Haruo Naito, "Eisai") and Purdue Pharma L.P. (President and CEO: Craig Landau, "Purdue Pharma") today announced positive topline results from multiple studies of lemborexant, an investigational agent for sleep and wake regulation currently being studied for the treatment of multiple sleep disorders.
- Source: finance.yahoo.
- 531
- March 9, 2018
Clinical Trials Eisai lemborexant multiple sleep disorders
FDA approves new HIV treatment for patients who have limited treatment options

Today, the U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR HIV). Trogarzo is administered intravenously once every 14 days by a trained medical professional and used in combination with other antiretroviral medications.
- Source: Prnewswire
- 484
- March 8, 2018
antiretroviral HIV New Approvals
Celgene Completes Acquisition of Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy

Celgene Corporation (NASDAQ:CELG) today announced that it has completed the acquisition of Juno Therapeutics, Inc. As a result, the common stock of Juno will no longer be listed for trading on the NASDAQ Global Select Market.
- Source: ir.celgene
- 589
- March 8, 2018
cellular immunotherapy Market Views
Medtec China 2018 scale will grow by 10% to feed the rapidly growing needs of the medical device industry in China

Medtec China 2018 is taking place on September 26–28 in Shanghai China. This year the scale of the show will grow by 10% reaching a new height since 2015; it is now at a scale making utilization of an entire hall possible to hold the show.
- Source: Ddu
- 1,548
- March 8, 2018
Exhibitions & Activities Medtec China
The Use of Internet of Things in Healthcare in 2018

The use of Internet of Things in Healthcare is going to be revolutionary in the next years. IoT is now pretty much in everything we touch in our modern lives, technology is now a common denominator in most of everybody’s life.
- Source: Digital Salutem
- 582
- March 8, 2018
EHR healthcare Internet of Things Market Views
AMRA and Siemens to enhance access to body composition analysis

AMRA has signed a new agreement to integrate its body composition analysis into Siemens Healthineers Digital Ecosystem for increased access to healthcare professionals and researchers. Intended to aid in disease prediction, AMRA’s body composition analysis is an automated method designed to convert a six-minute whole body MRI scan into 3D-volumetric fat and muscle measurements.
- Source: .medicaldevice-network
- 729
- March 8, 2018
body composition analysis Company Insight disease prediction Siemens
Exposure to smoke during pregnancy contributes to poorer lung function in children with asthma

New US research has found that smoking while pregnant could be even worse for children with asthma than exposing them to secondhand smoke in childhood.
- Source: msn
- 864
- March 8, 2018
asthma Researches secondhand smoke
First European filing acceptance of a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor in type-1 diabetes

AstraZeneca today announced that the European Medicines Agency has accepted the Marketing Authorisation Variation forForxiga (dapagliflozin), a selective SGLT-2 inhibitor, for use as an oral adjunct treatment to insulin in adults with type-1 diabetes (T1D).
- Source: astrazeneca
- 671
- March 7, 2018
AstraZeneca diabetes Forxiga insulin New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.